Hutton Scott's Form 4 filing
Biodesix Inc (BDSX) · filed Feb 10, 2023
- Accession no.
- 0001140361-23-006076
- Filed
- Feb 10, 2023
- Trade date
- Feb 8-9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $29.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hutton ScottCIK 0001697361 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Common Stock | MOption exerciseAcquired | +44,777 | – | – | 216,004 | Direct | |
| Feb 9, 2023 | Common Stock | SSaleDisposed | −16,278 | $1.80 | −$29,300.4 | 199,726 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Common Stock | AGrant or awardAcquired | +751,042 | $0.00 | $0 | 751,042 | Direct | |
| Feb 8, 2023 | Common Stock | MOption exerciseDisposed | −12,212 | $0.00 | $0 | 146,544 | Direct | |
| Feb 8, 2023 | Common Stock | MOption exerciseDisposed | −32,565 | $0.00 | $0 | 65,131 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.